These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 14631546)

  • 1. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias.
    Kes P; Pecanić Z; Getaldić B; Ratković-Gusić I
    Acta Med Croatica; 1996; 50(4-5):173-7. PubMed ID: 9046114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of plasma viscosity in monoclonal IgM gammopathies.
    Visentin I; Mares M; Bertolo C; Terribile V; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):747-58. PubMed ID: 1709909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood hyperviscosity syndromes].
    Crepaldi G; Calabrò A; Belloni M; Ongaro G; Muggeo M
    Ric Clin Lab; 1983; 13 Suppl 3():89-104. PubMed ID: 6424223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA myeloma complicated by fractures of the bones and hyperviscosity syndrome--report of an autopsied case.
    Tojo K; Morita A; Miki T; Morii H; Mitsuhashi T; Hashimoto R; Kadoya Y
    Osaka City Med J; 1990 May; 36(1):61-70. PubMed ID: 2385441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the hyperviscosity syndrome. II. Macroglobulinemia.
    MacKenzie MR; Babcock J
    J Lab Clin Med; 1975 Feb; 85(2):227-34. PubMed ID: 803540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and biohumoral significance of plasma viscosity in patients with paraproteinemia without clinical hyperviscosity syndrome. A study of 40 cases (author's transl)].
    Barbarano L; Rossi AF; Vendrami R; Van Westerhout G; Sala G; Canesi BA
    Haematologica; 1981 Aug; 66(4):452-60. PubMed ID: 6797880
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests.
    Beck JR; Quinn BM; Meier FA; Rawnsley HM
    Transfusion; 1982; 22(1):51-3. PubMed ID: 6801828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3+ T lymphocytes and interleukin 2 in myelomatous blood hyperviscosity syndrome treated with plasmapheresis.
    Usnarska-Zubkiewicz L
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):317-22. PubMed ID: 9832072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperviscosity syndrome in plasma cell dyscrasias].
    Somer T
    Duodecim; 1977; 93(9):586-603. PubMed ID: 406132
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
    Mullen EC; Wang M
    Clin J Oncol Nurs; 2007 Feb; 11(1):87-95. PubMed ID: 17441400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperviscosity syndrome].
    Dumas G; Merceron S; Zafrani L; Canet E; Lemiale V; Kouatchet A; Azoulay E
    Rev Med Interne; 2015 Sep; 36(9):588-95. PubMed ID: 25778852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.